ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,078.01
-0.65%
US Tech 100
21,339.20
-0.70%
다우존스 지수
43,784.48
-0.89%
Bitcoin
98,031.03
-0.29%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Caribou Biosciences Inc (CRBU) 시세

Caribou Biosciences Inc

Caribou Biosciences Inc (CRBU)

Amd Commo Exagr
1.365
-0.045
( -3.19% )
업데이트: 00:43:00
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
1.365
매수가
1.36
매도가
1.37
거래량
191,155
1.355 일간 변동폭 1.43
1.22 52주 범위 8.33
market_cap
123.604M
전일 종가
1.41
개장가
1.42
최근 거래 시간
100
@
1.365
마지막 거래 시간
00:43:00
재정 규모
US$ 267,023
VWAP
1.3969
평균 볼륨(3m)
1,393,251
발행 주식
90,552,687
배당수익률
-
주가수익률
-1.21
주당순이익(EPS)
-1.13
매출
34.48M
순이익
-102.07M

Caribou Biosciences Inc 정보

Caribou Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. Caribou Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies.

섹터
Biological Pds,ex Diagnstics
산업
Biological Pds,ex Diagnstics
웹사이트
www.cariboubio.com
본부
Dover, Delaware, USA
설립됨
-
Caribou Biosciences Inc is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker CRBU. The last closing price for Caribou Biosciences was US$1.41. Over the last year, Caribou Biosciences shares have traded in a share price range of US$ 1.22 to US$ 8.33.

Caribou Biosciences currently has 90,552,687 shares in issue. The market capitalisation of Caribou Biosciences is US$127.68 million. Caribou Biosciences has a price to earnings ratio (PE ratio) of -1.21.

CRBU 최신 뉴스

추가 뉴스

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
31 1월 2025
CRBU (-3.19%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.0151.111111111111.351.461.3210488941.40173795CS
4-0.175-11.36363636361.541.571.2212883811.38330026CS
12-0.845-38.23529411762.212.381.2213932511.67186836CS
26-0.815-37.38532110092.182.99951.2212790451.90428443CS
52-5.325-79.59641255616.698.331.2216514912.76670352CS
156-8.475-86.12804878059.8413.191.2213506094.98978833CS
260-16.285-92.266288951817.6532.6451.2212338136.24949978CS

CRBU - Frequently Asked Questions (FAQ)

What is the current Caribou Biosciences share price?
The current share price of Caribou Biosciences is US$ 1.365
How many Caribou Biosciences shares are in issue?
Caribou Biosciences has 90,552,687 shares in issue
What is the market cap of Caribou Biosciences?
The market capitalisation of Caribou Biosciences is USD 127.68M
What is the 1 year trading range for Caribou Biosciences share price?
Caribou Biosciences has traded in the range of US$ 1.22 to US$ 8.33 during the past year
What is the PE ratio of Caribou Biosciences?
The price to earnings ratio of Caribou Biosciences is -1.21
What is the cash to sales ratio of Caribou Biosciences?
The cash to sales ratio of Caribou Biosciences is 3.57
What is the reporting currency for Caribou Biosciences?
Caribou Biosciences reports financial results in USD
What is the latest annual turnover for Caribou Biosciences?
The latest annual turnover of Caribou Biosciences is USD 34.48M
What is the latest annual profit for Caribou Biosciences?
The latest annual profit of Caribou Biosciences is USD -102.07M
What is the registered address of Caribou Biosciences?
The registered address for Caribou Biosciences is 3500 S DUPONT HWY, KENT, DOVER, DELAWARE, 19901
What is the Caribou Biosciences website address?
The website address for Caribou Biosciences is www.cariboubio.com
Which industry sector does Caribou Biosciences operate in?
Caribou Biosciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
MLGOMicroAlgo Inc
US$ 4.71
(309.57%)
172.12M
UPCUniverse Pharmaceuticals Inc
US$ 0.315
(121.05%)
251.41M
OSRHOSR Holdings Inc
US$ 5.49
(59.13%)
18.98M
GDEVGDEV Inc
US$ 20.85
(46.21%)
65.22k
NKGNNKGen Biotech Inc
US$ 0.6349
(41.72%)
78.34M
DOYUDouYu International Holdings Ltd
US$ 7.135
(-55.66%)
610.94k
MNDRMobile health Network Solutions
US$ 0.5625
(-40.15%)
9.3M
BLUEbluebird bio Inc
US$ 4.26
(-39.49%)
3.38M
AXTIAXT Inc
US$ 1.6678
(-27.17%)
2.92M
REBNReborn Coffee Inc
US$ 5.6695
(-22.55%)
929.79k
UPCUniverse Pharmaceuticals Inc
US$ 0.315
(121.05%)
251.41M
MLGOMicroAlgo Inc
US$ 4.71
(309.57%)
172.12M
ADTXAditxt Inc
US$ 0.1177
(-0.93%)
87.51M
NKGNNKGen Biotech Inc
US$ 0.6349
(41.72%)
78.34M
NAASNaaS Technology Inc
US$ 1.962
(41.15%)
69.19M

CRBU Discussion

게시물 보기
theorysuit theorysuit 3 주 전
What do you think of their shift to partial HLA matching?
👍️0
Monksdream Monksdream 2 월 전
CRBU. Under $2
👍️0
Monksdream Monksdream 2 월 전
CRBU under $2
👍️0
TrendTrade2016 TrendTrade2016 3 월 전
CRBU READY TO BEAST
👍️0
TrendTrade2016 TrendTrade2016 4 월 전
CRBU...NEW SCAN JUST GAVE ME THIS BIO
👍️0
Monksdream Monksdream 4 월 전
CRBU under $3
👍️0
Monksdream Monksdream 5 월 전
CRBU under $2
👍️0
Monksdream Monksdream 6 월 전
CRBU under $3
👍️0
Monksdream Monksdream 7 월 전
CRBU under $3
👍️0
jondoeuk jondoeuk 7 월 전
Earlier this year development of the lead CAR-NK programme, CB-020, was stopped, and now they are out of CAR-NK altogether. They disclosed it in an SEC filing and outlined a 12% workforce reduction https://www.sec.gov/Archives/edgar/data/1619856/000161985624000054/crbu-20240716.htm

This should extend their cash runway by at least six months, into the second half of 2026.
👍️0
Monksdream Monksdream 7 월 전
CRBU under $3
👍️0
Monksdream Monksdream 8 월 전
CRBU new 52 week low
👍️0
Monksdream Monksdream 8 월 전
CRBU new 52 week low
👍️0
NY1972 NY1972 8 월 전
Without engaging macrophage long term, CART and other ACT will have persistence issue as regulatory lymphocytes and TAM recoup. AFMD has the best approach with ICE engaging a few B CBNK cells for start and engaging endogenous NK and M in the maintenance phase
👍️0
Diego Rivas Diego Rivas 9 월 전
Any good news in here comming?
👍️0
jondoeuk jondoeuk 9 월 전
Among patients with four or more matching HLA alleles, mPFS was 14.4 months, versus 2.8 months in patients with three or fewer matches. But this is based on a retrospective analysis, so they will need to prove the theory prospectively. It was better in LBCL, with mPFS not reached, versus 2.8 months. Also, some improvement in the now-selected dose, 80 million CAR-T cells.
👍️0
jondoeuk jondoeuk 9 월 전
The BCMA-targeted space is already crowded enough and off-target toxicities, including agranulocytosis* could be a problem for its anti-CLL-1 CAR.

* CLL-1 is also highly expressed on almost all granulocytes and monocytes and on parts of myeloid progenitors in the normal bone marrow and peripheral blood.
👍️0
Monksdream Monksdream 9 월 전
CRBU new 52 week low
👍️0
stocksrising stocksrising 9 월 전
Yep, not a positive trend hence sub $3’s…fortunately other trials for varied indications could save company…
👍️0
jondoeuk jondoeuk 9 월 전
It gets worse. The updated (CB-010) data shows that the ORR (including CR rate) has fallen, so has the mDOR, the six-month PFS is poor and the pivotal trial has been delayed until H2 2025 following a new HLA partial matching strategy. The latter completely alters (in a bad way) the commercial strategy for an allo CAR-T product. They now need thirteen different off-the-shelf batches to be able to cater to ~90% of patients based on an ideal HLA match.
👍️ 1
Monksdream Monksdream 9 월 전
CRBU new 52 week low
👍️0
Monksdream Monksdream 9 월 전
CRBU new 52 week low
👍️0
Monksdream Monksdream 10 월 전
CRBU under $5
👍️0
stocksrising stocksrising 11 월 전
It seemed like they were running on all positive cylinders, but must have blown a gasket at current Conference/ Fireside???
👍️0
Monksdream Monksdream 1 년 전
CRBU new 52 week low
👍️0
jondoeuk jondoeuk 2 년 전
Yes, with both drugs still in development. As for CRBU, they gave an update (plus public offering) https://finance.yahoo.com/news/caribou-biosciences-reports-positive-clinical-200100822.html https://investor.cariboubio.com/static-files/d818ed1a-aea2-41c1-84ea-bd05a4276cbb

Personally, there seem to be red flags, such as no expansion/persistence data. I know they give huge amounts of LD chemo, higher (I think) than anyone else, which could be generating responses, explaining why there is no dose response.
👍️0
trueblue trueblue 2 년 전
.
👍️0
trueblue trueblue 2 년 전
$23.00 price target! Now that is a good start!! Glad I loaded up! Jmo
👍️0
NY1972 NY1972 2 년 전
Didn't they buy TRIL? Just gambling with billions from US government.
👍️0
jondoeuk jondoeuk 2 년 전
PFE is very selective in who they fund https://finance.yahoo.com/news/caribou-biosciences-announces-25-million-120000433.html
👍️0
trueblue trueblue 2 년 전
Great day in my accounts again! Really liking my CRBU shares! Jmo holding for the long haul!!
👍️0
Monksdream Monksdream 2 년 전
CRBU now No 9 on the Barchart Top 10
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
trueblue trueblue 2 년 전
Added to my existing shares today, I bought shares months ago. I like Crbu a crisper company! Looks like Pfizer does also! Jmo
👍️0
Stockexpertpro Stockexpertpro 2 년 전
CRBU Loss 108 Million Dollars Company only has preclinical and phase 1 in its pipeline company is Years away from having anything if ever did a stock offering at 5.33$ for 25 Million thats only 1 QTR Cash burn for this company Sell the News https://www.cariboubio.com/pipeline/
👍️0
TheFinalCD TheFinalCD 2 년 전
CRBU= JUST WOW

https://finviz.com/quote.ashx?t=CRBU&ty=c&ta=1&p=d
👍️0
Monksdream Monksdream 2 년 전
CRBU No 1 on the early Barchart Top 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0

최근 히스토리

NASDAQ
CRBU
Caribou Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지